Back to results
US 2022/0017632 A1Published application
Anti-ox40 monoclonal antibody and application thereof
AssigneeHanx Biopharmaceutics, Inc
InventorsYing HUANG, Faming ZHANG, Hang KE
Life of this patent
Estimating the term…
Abstract
Provided in the present invention are an anti-OX40 monoclonal antibody or an antigen-binding fragment thereof, and a corresponding isolated polynucleotide, expression vector, recombinant cell, pharmaceutical composition, and application thereof. The present antibody can be used for the treatment of cancer or autoimmune disease.
Claims20
An anti-OX40 antibody or antigen-binding fragment thereof, comprising at least one of:
- (1) a heavy chain variable region comprising amino acid sequences of GFTFSDYY SEQ ID NO:
- 18, ISDGGSNT SEQ ID NO:
- 19 and ARRGTGTGFGY SEQ ID NO:
- 20, and a light chain variable region comprising amino acid sequences of ENIYST SEQ ID NO:
- 21, AAT and QHFWGIPWT SEQ ID NO:
- 22;
- (2) a heavy chain variable region comprising amino acid sequences of GYTFTNYD SEQ ID NO:
- 23, IYPEDGST SEQ ID NO:
- 24 and ARDTRGYFDY SEQ ID NO:
- 25, and a light chain variable region comprising amino acid sequences of SSVNY SEQ ID NO:
- 26, YTS and QQFTSSPWT SEQ ID NO:
- 27;
- (3) a heavy chain variable region comprising amino acid sequences of GDSITSGY SEQ ID NO:
- 28, ISFSGNT SEQ ID NO:
- 29 and ARYPYSYSNWDYAMDY SEQ ID NO:
- 30, and a light chain variable region comprising amino acid sequences of QFLLYSSSQKNY SEQ ID NO:
- 31, WAS and HQYYSYPLT SEQ ID NO:
- 32;
- (4) a heavy chain variable region comprising amino acid sequences of GDSITIGF SEQ ID NO:
- 33, INYSGSS SEQ ID NO:
- 34 and ARSGTDLDY SEQ ID NO:
- 35, and a light chain variable region comprising amino acid sequences of QSLLDSDGKTY SEQ ID NO:
- 36, LVS and WQGTHFPRT SEQ ID NO:
- 37;
- and
- (5) an amino acid sequence of any of (1) to (4) with one or more conservative amino acid substitutions.
23 more elements
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.